|
Cano-Marmol RP, Fernandez-Ruiz VE, Martinez-Pascual C, Ros-Madrid I, Martin-Pozuelo G, Oliva-Bolarin A, Martinez-Sanchez MA, Egea-Valenzuela J, Nunez-Sanchez MA, Ramos-Molina B, Ruiz-Alcaraz AJ, Ferrer-Gomez M. Corporal Composition and Gut Microbiome Modification Through Exclusion Dietary Intervention in Adult Patients with Crohn's Disease: Protocol for a Prospective, Interventional, Controlled, Randomized Clinical Trial. J Clin Med. 2025 Jun 5;14(11):3998. doi: 10.3390/jcm14113998. PubMed PMID: 40507757.
AÑO: 2025; IF: 2.9
|
40507757
|
Ros-Madrid I, Cano-Marmol RP, Ferrer-Gomez M, Ramos-Molina B. ANTI-INFLAMMATORY PROPERTIES OF GLP-1 RECEPTOR AGONISTS AND OTHER ANCILLARY BENEFITS FROM A PHARMACOLOGICAL PERSPECTIVE. Can J Physiol Pharmacol. 2025 Oct 14. doi: 10.1139/cjpp-2025-0148. Online ahead of print. PubMed PMID: 41086442.
AÑO: 2025; IF: 1.3
|
|
Ros-Madrid I, Febrero B, Cano-Marmol RP, Ferrer-Gomez M, Rodriguez JM. Predictors of Distant Metastasis in Patients with Medullary Thyroid Carcinoma. Cancers (Basel). 2025 Sep 30;17(19):3193. doi: 10.3390/cancers17193193. PubMed PMID: 41097721.
AÑO: 2025; IF: 4.4
|
|
Cano-Marmol RP, Ros-Madrid I, Andreo-Lopez MC, Munoz-Torres M. Hypophosphatemia in the Diagnosis and Management of Primary Hyperparathyroidism. J Clin Med. 2025 Oct 3;14(19):7024. doi: 10.3390/jcm14197024. PubMed PMID: 41096103.
AÑO: 2025; IF: 2.9
|
|
Febrero B, Ros-Madrid I, Revilla-Nuin B, Abellan M, Ruiz-Manzanera JJ, Gomez J, Rodriguez JM. Could microRNA Analysis Help in the Management of Medullary Thyroid Cancer? Cancers (Basel). 2025 Feb 13;17(4):629. doi: 10.3390/cancers17040629. PubMed PMID: 40002224; PubMed Central PMCID: PMC11853104.
AÑO: 2025; IF: 4.4
|